Six crore vaccine shots are ready, but only two crores delivered in the Covaxin puzzle. What happened to the others?
The mismatch between declared Covid vaccine manufacturing numbers in India.
In the case of Covaxin, the degree of daily vaccination appears to be extremely high. According to official data, Bharat Biotech’s vaccine had administered in 21 crore doses across the country as of Thursday morning.
When the company’s and the government’s statements are combined, it appears that at least six crore dosages should have been available for usage in India. So, where are the other two-thirds?
Despite numerous attempts, Bharat Biotech, situated in Hyderabad, has declined to reply.
Take a look at the production figures. On April 20, the company’s CMD, Krishna Ella, said that it produced 15 million pills in March and that April’s output will be 20 million doses. He also stated that production would be 30 million or three crores in May, but let us assume that the anticipated scaling up did not occur. Still, 35 million doses in March and April, with a large portion of another 20 million in May.
Covaxin production is at two crore doses every month, according to at least two separate affidavits filed by the Centre, one in the Supreme Court and the other in the Kerala High Court as recently as May 24. All of this adds up to a near-5.5 crore dosage output by the end of May.
Bharat Biotech’s CMD, Krishna Ella, revealed on January 5 that the company had stockpiled 20 million doses of the vaccine before the vaccination program had started. The amount now stands at 7.5 crores. When you include in output in January and February, which was significantly lower than in March and April, you’re looking at roughly eight crore doses.
Of course, some of this could have transferred as part of the country’s vaccine diplomacy. However, India’s total vaccine exports are around 6.6 crore doses. Covishield has accounted for the majority of this. Even if two crores of them were Covaxin,
By this time, in the most unlikely case, India should have had six crore doses available for usage. What accounts for the consumption of merely 2.1 crores? Covaxin has been in short supply in a number of states. Even for those waiting for a second shot, the government in Delhi had to close Covaxin administration centres this week.
According to the data, the extent to which different states have used Covaxin differs significantly. Covaxin has a nearly 31 per cent market share in Delhi, far more significant than in any other state/UT. Here 14 of the smaller states and UTS, no single dose of Covaxin was given, and in five others, the injection amounted to less than 5% of the total. States/UTs like Delhi are more vulnerable to supply chains since many people are waiting for a second dose of the Bharat Biotech vaccine.
STAY HEALTHY, STAY SAFE
GET VACCINATED AS SOON AS POSSIBLE
THROW YOUR MASK ONLY INTO THE DUST BIN
FOLLOW ALL THE GUIDELINES OF THE GOVERNMENT